Nisa Investment Advisors LLC Decreases Position in Revvity Inc. (NYSE:RVTY)

Nisa Investment Advisors LLC cut its holdings in Revvity Inc. (NYSE:RVTY - Free Report) by 4.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 75,748 shares of the company's stock after selling 3,508 shares during the period. Nisa Investment Advisors LLC owned 0.06% of Revvity worth $8,014,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Assetmark Inc. increased its stake in shares of Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares during the period. Optiver Holding B.V. bought a new position in Revvity during the fourth quarter valued at about $33,000. Quarry LP increased its stake in Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares during the period. Millstone Evans Group LLC bought a new position in Revvity during the fourth quarter valued at about $38,000. Finally, Vermillion Wealth Management Inc. bought a new position in Revvity during the fourth quarter valued at about $41,000. 86.65% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

RVTY has been the topic of a number of recent research reports. JPMorgan Chase & Co. decreased their price objective on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and decreased their price objective for the company from $145.00 to $115.00 in a report on Thursday, May 1st. Raymond James Financial reissued an "outperform" rating and issued a $120.00 target price (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Bank of America reduced their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Finally, Wall Street Zen raised Revvity from a "hold" rating to a "buy" rating in a report on Saturday, June 28th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $123.07.

Revvity Price Performance

NYSE RVTY traded down $0.91 on Friday, hitting $101.49. The stock had a trading volume of 676,357 shares, compared to its average volume of 976,872. Revvity Inc. has a 52-week low of $87.70 and a 52-week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58. The company has a market capitalization of $11.96 billion, a price-to-earnings ratio of 43.19, a price-to-earnings-growth ratio of 2.58 and a beta of 0.98. The firm has a 50-day moving average of $94.71 and a 200-day moving average of $104.53.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million for the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The business's quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter last year, the company posted $0.98 EPS. Equities analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is presently 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.